ZONK Drug R&D Limited, the registered capital of 5 million yuan, is located in Guangzhou Tianhe Hi-Tech Industrial Zone in the science and technology park for the new Guangzhou City high-tech enterprises. We have 400 square meters of modern laboratory with analysis, synthesis apparatus and a professional production base in Liaoning province. The main directions of our R&D are tumors, cardiovascular and cerebrovascular chemical innovative drug research. We have applied more than 20 patent applications, three of which have already been authorized , two of them are new compounds for the international PCT patent applications. The pre-clinical studies of Binaprofen ,a non-steroidal anti-inflammation drug, have been completed ,and in registration stage in SFDA now, we have applied the International PCT patent of this compound, PCT application No:PCT/CN2007/002830.The new antineoplastic agents COPEN initial drug evaluation has been completed, with a variety of tumor cell apoptosis clear role, the new compounds have applied for patents in china and PCT. At the same time, we also do the research and production of pharmaceutical chemicals and intermediates, we have a production base of API in Dalian, we are now manufacturing Balsalazide, Estramustine phosphate, Pilsicainide, Tenofovir, Distigmine Bromide,3-Furaldehyde. We welcome friends from all the world to cooperate , we can produce compounds according to your order . Main Direction: 1, innovative small molecule drugs chemical drug research 2, pharmaceutical raw materials, intermediates development, production, sales Pharmaceutical raw materials and intermediates: